GE HealthCare Technologies (General Electric Company Spin-Off) (Seite 2)
eröffnet am 29.12.22 21:14:09 von
neuester Beitrag 21.11.23 07:17:00 von
neuester Beitrag 21.11.23 07:17:00 von
Beiträge: 17
ID: 1.365.820
ID: 1.365.820
Aufrufe heute: 0
Gesamt: 3.333
Gesamt: 3.333
Aktive User: 0
ISIN: US36266G1076 · WKN: A3D3G6 · Symbol: L0T
72,01
EUR
-0,74 %
-0,54 EUR
Letzter Kurs 12:32:48 Tradegate
Neuigkeiten
| Titel |
|---|
| GE Healthcare Technologies Aktien ab 5,80 Euro handeln - Ohne versteckte Kosten!Anzeige |
22.05.24 · Business Wire (engl.)  |
15.05.24 · BNP Paribas Anzeige |
14.05.24 · Business Wire (engl.) |
13.05.24 · wO Newsflash |
Werte aus der Branche Gesundheitswesen
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,5289 | +147,50 | |
| 2,0999 | +33,79 | |
| 0,6400 | +24,27 | |
| 4,3500 | +23,93 | |
| 2,0600 | +19,08 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,5150 | -14,17 | |
| 1,7500 | -14,63 | |
| 14,170 | -14,89 | |
| 0,5650 | -33,53 | |
| 0,9000 | -53,85 |
Beitrag zu dieser Diskussion schreiben
Feedback
10.1.
GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook
https://www.wallstreet-online.de/nachricht/16414475-ge-healt…
...
Mr. Arduini said, “We delivered strong year-over-year revenue growth in the fourth quarter and full year, reflecting robust customer demand, backlog fulfillment, and improved pricing.
While inflation remains a factor, we are seeing the supply chain environment continue to improve with demand for our products and services growing in 2023. We are also pleased to provide our financial outlook for 2023, reflecting continued growth as we execute on our strategic plan. As we look ahead, we see significant opportunities to innovate and solve some of the most significant clinical challenges with our precision care strategy.”
...
The Company expects full year 2023 results as follows:
• Organic revenue growth* in the range of 5% to 7% year over year.
• Adjusted EBIT margin* of 15.0% to 15.5%, reflecting an expansion of 50 basis points to 100 basis points versus its 2022 Pro forma Adjusted EBIT margin*.
• Free cash flow conversion* of 85%+.
The Company provides its outlook on a non-GAAP basis. Refer to the Outlook section in the discussion of non-GAAP financial measures below for more details.
GE HealthCare will report fourth quarter and full year 2022 results on January 30, 2023, followed by a conference call at 8:00 am ET.
...
GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook
https://www.wallstreet-online.de/nachricht/16414475-ge-healt…
...
Mr. Arduini said, “We delivered strong year-over-year revenue growth in the fourth quarter and full year, reflecting robust customer demand, backlog fulfillment, and improved pricing.
While inflation remains a factor, we are seeing the supply chain environment continue to improve with demand for our products and services growing in 2023. We are also pleased to provide our financial outlook for 2023, reflecting continued growth as we execute on our strategic plan. As we look ahead, we see significant opportunities to innovate and solve some of the most significant clinical challenges with our precision care strategy.”
...
The Company expects full year 2023 results as follows:
• Organic revenue growth* in the range of 5% to 7% year over year.
• Adjusted EBIT margin* of 15.0% to 15.5%, reflecting an expansion of 50 basis points to 100 basis points versus its 2022 Pro forma Adjusted EBIT margin*.
• Free cash flow conversion* of 85%+.
The Company provides its outlook on a non-GAAP basis. Refer to the Outlook section in the discussion of non-GAAP financial measures below for more details.
GE HealthCare will report fourth quarter and full year 2022 results on January 30, 2023, followed by a conference call at 8:00 am ET.
...
Was für ein Tag an Mega-Umschichtungen bei $GE und $GEHC:
Wird wahrscheinlich der gleiche
" Erfolg " wie deine Pharol 
Überall wo getrommelt wird, heißt es generell: Finger weg
Ich tippe mal darauf, dass diese Neuemisson den gleichen Weg geht wie Warner Bros Discovery nach der AT&T Abspaltung, also mindestens minus 50 % in den nächsten 12 Monaten.
Antwort auf Beitrag Nr.: 72.994.303 von faultcode am 29.12.22 21:19:46
Trading Spotlight
Antwort auf Beitrag Nr.: 72.994.285 von faultcode am 29.12.22 21:14:0929.12.
General Electric-Aktie und GE Healthcare-Aktie freundlich: GE HealthCare Technologies-Aktie steigt in S&P 500 ein
https://www.finanzen.net/nachricht/aktien/index-aenderung-ge…
...
Die Aktien von GE HealthCare Technologies, ein im November ausgegliederter Bereich von General Electric, werden neu in den S&P 500 aufgenommen.
...
--> $GEHCV: https://www.marketwatch.com/investing/stock/gehcv?mod=search…
General Electric-Aktie und GE Healthcare-Aktie freundlich: GE HealthCare Technologies-Aktie steigt in S&P 500 ein
https://www.finanzen.net/nachricht/aktien/index-aenderung-ge…
...
Die Aktien von GE HealthCare Technologies, ein im November ausgegliederter Bereich von General Electric, werden neu in den S&P 500 aufgenommen.
...
--> $GEHCV: https://www.marketwatch.com/investing/stock/gehcv?mod=search…
aus dem INFORMATION STATEMENT vom 2.12.:
The Spin-Off will be effective as of 5:00 p.m., New York City time, on January 3, 2023. Immediately after the Spin-Off becomes effective, we will be an independent, publicly traded company.
...
We have applied to list our common stock on The Nasdaq Stock Market LLC under the ticker symbol “GEHC.”
...
The Spin-Off will be effective as of 5:00 p.m., New York City time, on January 3, 2023. Immediately after the Spin-Off becomes effective, we will be an independent, publicly traded company.
...
We have applied to list our common stock on The Nasdaq Stock Market LLC under the ticker symbol “GEHC.”
...
Durchsuchen
13.05.24 · wO Newsflash · Carl Zeiss Meditec |
04.05.24 · wO Chartvergleich · American Express |
30.04.24 · dpa-AFX · Coca-Cola |